☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
BMS
BMS Reports the US FDA’s Acceptance of BLA for Opdivo to Treat Clear Cell Renal Cell Carcinoma
May 6, 2024
BMS Highlights Data from the P-I/II Study of Krazati Plus Cetuximab to Treat Locally Advanced or Metastatic Colorectal Cancer at t...
April 9, 2024
BMS Highlights Pooled Interim Data from the P-III (EMERGENT) Program of KarXT for Schizophrenia at the SIRS 2024
April 8, 2024
BMS Reports the EC’s Expanded Approval of Reblozyl as a 1L Treatment of Transfusion-Dependent Anemia Due to Myelodysplastic Syndro...
April 3, 2024
BMS’ Abecma Receives EC’s Approval for the Treatment of Relapsed/Refractory Multiple Myeloma
March 21, 2024
PharmaShots Weekly Snapshots (March 11 – March 15, 2024)
March 15, 2024
Load more...
Back to Home